Dr Ray Manneh Kopp

Go Back

Medical Oncologist

  • Sociedad de Oncología y Hematología del Cesar
  • location Colombia

Scientific director at Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia. Chief of Genitourinary Unit and Clinical Research Unit. Medical Oncologist at Clínica Portoazul, Barranquilla, Colombia. I completed medical school at Universidad del Norte, Barranquilla Colombia.  Medical oncologist from University Hospital 12 de Octubre in Madrid, Genitourinary Fellow in the GU unit at  University Hospital 12 de Octubre. Master in molecular oncology from Centro de estudios biosanitarios, CNIIO, ESO. Founder of Grupo de Oncología Genitourinaria de Colombia.  Member of SEOM, ACHO and LACOG-GU. I focus my practice on patients with prostate, bladder, kidney and testicular cancer. 

Dr Ray Manneh Kopp has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Astellas, AstraZeneca, BMS, Dr Reddys, Roche, Janssen, Lilly, MSD, Novartis and Technofarma.

Programmes developed by Dr Ray Manneh Kopp

Episode

2

of 2

episode
Oncology 
GU CONNECT Prostate Cancer Update from ESMO 2022

Episode 2: Presidential Sessions

Experts
Prof. Neeraj Agarwal, Dr Ray Manneh Kopp
  • clock 4 MIN
  • calendar Sep 2022

Educational programme supported by an Independent Medical Education grant from Bayer

Episode

1

of 2

episode
Oncology 
GU CONNECT Prostate Cancer Update from ESMO 2022

Episode 1

Experts
Prof. Neeraj Agarwal, Dr Ray Manneh Kopp
  • download Downloadable
    Resources
  • clock 8 MIN
  • calendar Sep 2022

Educational programme supported by an Independent Medical Education grant from Bayer
Oncology 
Update From ESMO 2022 Presidential Sessions

COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.

Experts
Dr Thomas Winder, Dr Ray Manneh Kopp, Dr Alfredo Addeo
  • clock 10 MIN
  • calendar Sep 2022

Oncology 
Individualising treatment strategies for nmCRPC

Dr. Ray Manneh Kopp discusses treatment strategies for non-metastatic castration-resistant prostate cancer (nmCRPC) and how to individualise them to the patient.

Experts
Dr Ray Manneh Kopp
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Oct 2021

Educational programme supported by an Independent Medical Education grant from Bayer
Oncology 
Highlights of 2020 in prostate, urothelial and kidney cancer

Dr Ray Manneh Kopp takes a look at the highlights of 2020 from GU CONNECT.

Experts
Dr Ray Manneh Kopp
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2021

Educational programme supported by an Independent Medical Education grant from Bayer